Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-007030
Filing Date
2019-11-12
Accepted
2019-11-12 16:30:18
Documents
1
Period of Report
2019-11-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-46121.html 4  
1 PRIMARY DOCUMENT marketforms-46121.xml 4 3149
  Complete submission text file 0001214659-19-007030.txt   4655
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HUMANIGEN, INC. 1000 MARINA BOULEVARD, SUITE 250 BRISBANE CA 94005-1878
Business Address
Boehm Rainer J. (Reporting) CIK: 0001732381 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 191209980